SMTL ID : 6i10.1

CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

1 x GZK: 1-[(3~{R})-1,1-bis(oxidanylidene)thiolan-3-yl]-5-[(3,4-dichlorophenyl)methyl]pyrazolo[3,4-d]pyrimidin-4-one(Non-covalent)

GZK.1: 14 residues within 4Å: Chain A: F.14, L.16, L.48, A.58, V.60, I.93, W.101, L.103, V.134, L.214, E.215, F.216, R.217 Ligands: ACT.2 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.48, A:I.93, A:W.101, A:V.134, A:E.215, A:F.216 Hydrogen bonds: A:F.216 pi-Stacking: A:F.14

1 x ACT: ACETATE ION(Non-functional Binders)

ACT.2: 6 residues within 4Å: Chain A: W.101, V.134, Y.186, T.213, L.214 Ligands: GZK.1 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:V.134 Hydrogen bonds: A:V.134, A:L.214 Water bridges: A:V.134, A:V.134

3 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 7 residues within 4Å: Chain A: L.380, I.381, N.382, R.383, P.384, L.416, F.418 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:I.381, A:R.383, A:L.416 EDO.4: 8 residues within 4Å: Chain A: W.340, D.342, R.343, R.344, I.345, L.377, M.378, G.421 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.342, A:M.378 EDO.5: 6 residues within 4Å: Chain A: I.17, N.18, N.21, R.100, S.133, Q.184 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:I.17, A:R.100

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Francis, S. et al., Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents. Bioorg.Med.Chem.Lett. (2019)

Release Date

2019-02-27

Peptides

Fascin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Fascin

Related Entries With Identical Sequence